Angitia Bio

Angitia Biopharmaceuticals develops innovative therapeutics for musculoskeletal diseases, including treatments for osteoporosis and spinal fusion.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series D
Initial Investment Year
2026
Angitia Portco Hover Image1